⌘K

Login Start Free

Home/Filings/4/0001607062-16-000682

4//SEC Filing

GENEREX BIOTECHNOLOGY CORP 4

Accession 0001607062-16-000682

CIK 0001059784operating

View on SEC.gov Company Profile

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 5:02 PM ET

Size

6.6 KB

Accession

0001607062-16-000682

Insider Transaction Report

Form 4

Period: 2016-02-16

GENEREX BIOTECHNOLOGY CORPGNBT

EVP & General Counsel

Transactions

Exercise/Conversion
Common Stock
2016-02-16$0.00/sh+4,447,111$4,447→ 15,821,836 total
Exercise/Conversion
Common Stock Purchase Option
2016-02-16−4,447,111→ 0 total
Exercise: $0.00From: 2016-02-09Exp: 2020-10-26→ Common Stock (4,447,111 underlying)

Documents

1 file

4
fletcher021616form4.xmlPrimary
FORM 4

Issuer

GENEREX BIOTECHNOLOGY CORP

CIK 0001059784

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001059784

Filing Metadata

Form type: 4
Filed: Feb 15, 7:00 PM ET
Accepted: Feb 16, 5:02 PM ET
Size: 6.6 KB

View on SEC.gov